• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,608.98 49.74
( 0.07%)
Global Indices
Nasdaq
49,785.17 59.69
(0.12%)
Dow Jones
7,421.51 -12.33
(-0.17%)
Hang Seng
63,198.64 456.07
(0.73%)
Nikkei 225
10,300.99 35.67
(0.35%)
Forex
USD-INR
95.14 0.72
(0.77%)
EUR-INR
111.99 0.76
(0.69%)
GBP-INR
129.47 0.85
(0.66%)
JPY-INR
0.61 0.00
(0.51%)

EQUITY - MARKET SCREENER

Infinium Pharmachem Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78690
INE0MRE01011
67.8370031
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
INFINIUM
39.78
336.6
EPS(TTM)
Face Value()
Div & Yield %
5.43
10
0
 

idfc first bank ltd
SML Mahindra records 16% YoY growth in February production numbers
Mar 09,2026

During the month, the company recorded sales of 1,415 units compared with 1,229 units a year earlier, up 15% YoY.

Exports increased to 88 units in February 2026 from 59 units in February 2025.

SML Mahindra (formerly known as SML Isuzu) is primarily engaged in the business of the manufacture and sale of commercial vehicles and their parts.

The company’s standalone net profit surged 3,209.43%, while revenue from operations increased 62.53% in Q3 FY26.

The scrip was locked in 5% upper circuit at Rs 3991.95 on the BSE.